Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26980719 | 0.89 | TSHR (0.53) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL27645671 | 0.87 | TSHR (0.41) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL24963 | 0.85 | TSHR (0.52) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL4593744 | 0.83 | THRB (0.52) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL7738340 | 0.83 | TSHR (0.50) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL17922737 | 0.82 | TSHR (0.53) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL555904 | 0.82 | THRB (0.50) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL41669 | 0.82 | TSHR (0.63) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL496658 | 0.82 | TSHR (0.57) | TSHRTHRBALDH1A1POLBAPEX1 | |
| Propane SCHEMBL8440363 | 0.81 | THRB (0.50) | TSHRTHRBALDH1A1POLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LTD (AU) | 2026-02-05 | — | — | US | claimed |
| EP-4562077-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NewSouth Innovations Pty Limited (AU) | 2025-06-04 | — | — | EP | claimed |
| EP-3847220-B1 | UV-CURABLE HOT MELT ADHESIVE COMPOSITIONS FOR FLOORING APPLICATIONS | BASF SE (DE) | 2025-03-05 | — | — | EP | claimed |
| WO-2024020649-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2024-02-01 | — | — | WO | claimed |
| US-20240002736-A1 | RANDOM ACRYLIC TERPOLYMERS OF CONTROLLED MOLECULAR MASS USEFUL AS WATER IN CRUDE OIL EMULSIONS DESTABILIZERS | INSTITUTO MEXICANO DEL PETRÓLEO (MX) | 2024-01-04 | — | — | US | claimed |
| EP-3204444-B1 | PHOSPHATE ESTER-MODIFIED ACRYLIC POLYOLS | BASF SE (DE) | 2023-08-30 | — | — | EP | claimed |
| WO-2022261721-A1 | HEALABLE AND REPROCESSABLE COMPOSITIONS | DEAKIN UNIVERSITY (AU) | 2022-12-22 | — | — | WO | claimed |
| WO-2022228846-A1 | METHOD FOR PRODUCING A TERMINAL-FUNCTIONAL POLYMER | BASF SE (DE) | 2022-11-03 | — | — | WO | claimed |
| WO-2022117389-A1 | METHOD FOR PRODUCING A TERMINAL-FUNCTIONAL POLYMER | BASF SE (DE) | 2022-06-09 | — | — | WO | claimed |
| US-20210340408-A1 | UV-CURABLE HOT MELT ADHESIVE COMPOSITIONS FOR FLOORING APPLICATIONS | BASF SE (DE) | 2021-11-04 | — | — | US | claimed |
| US-6433052-B1 | SUPPORT RESIN FOR USE IN WATER-BASED INKS COMPRISED OF ACRYLATE/STYRENE COPOLYMER, ROSIN, AND FATTY ACID; NO SOLVENT STRIPPING REQUIRED; GOOD STABILITY AND VISCOSITY CHARACTERISTICS | WESTVACO CORPORATION | 2002-08-13 | — | — | US | claimed |
| US-6429247-B1 | PRODUCED BY POLYMERIZING MIXTURE OF VINYLIC MONOMERS IN PRESENCE OF FATTY ACID ROSIN MIXTURE TO PRODUCE A ROSIN-FATTY ACID VINYLIC POLYMER, SUBSEQUENTLY EMULSION POLYMERIZING ANOTHER MIXTURE OF VINYLIC MONOMERS | WESTVACO CORPORATION | 2002-08-06 | — | — | US | claimed |
| EP-1215221-A1 | Rosin-fatty acid vinylic emulsion compositions | WESTVACO CORPORATION (US) | 2002-06-19 | — | — | EP | claimed |
| US-6388026-B1 | CONTINUOUS PROCESS USING ACRYLATE; PROCESS CONTROL | S. C. JOHNSON COMMERCIAL MARKETS, INC. | 2002-05-14 | — | — | US | claimed |
| US-6329068-B1 | FOR PAPER AND OTHER CELLULOSIC BASE MATERIALS, (METH)ACRYLIC AND VINYLIC MONOMERS. | WESTVACO CORPORATION | 2001-12-11 | — | — | US | claimed |
| US-6172149-B1 | MADE BY REACTING A FATTY ACID ROSIN MIXTURE WITH (METH)ACRYLIC ACID, FUMARIC ACID, AND/OR MALEIC ANHYDRIDE, A VINYLIC MONOMER, AN INITIATOR, CHAIN TRANSFER AGENT AND UP TO 30 WEIGHT % HYDROCARBON SOLVENT, DISPERSING IN WATER | WESTVACO CORPORATION | 2001-01-09 | — | — | US | claimed |
| EP-0994123-A2 | Rosin-fatty acid vinylic polymer compositions | WESTVACO CORPORATION (US) | 2000-04-19 | — | — | EP | claimed |
| US-5258355-A | Graft polymer with unsaturated ester groups forming shells | AGFA-GEVAERT AKTIENGESELLSCHAFT | 1993-11-02 | — | — | US | claimed |
| US-4396706-A | ADDITION INTERPOLYMER PARTICLES, MATTES | FUJI PHOTO FILM CO., LTD. (JP) | 1983-08-02 | — | — | US | claimed |
| US-4117235-A | NOVEL PREPARATION OF NOVEL LOW MOLECULAR WEIGHT, LIQUID POLYMER | OWENS-ILLINOIS, INC. (US) | 1978-09-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | PIEZO1, LCP1, MTCL3 | TSHR 4571/4885THRB 4630/4885ALDH1A1 4717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.